Frozen Shoulder Treatment Market - Global Industry Analysis

Frozen Shoulder Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Medical Device Report Format : PDF Report Code: ZMR-5520 Status : Upcoming

Description

Frozen Shoulder Treatment Market : Overview

Frozen shoulder is the common term for adhesive capsulitis and this is the shoulder condition that restricts the motion. In frozen shoulder condition, the tissues of the shoulder joint has become tight and thick and scar tissue is created within a specified time. The most common symptoms of frozen shoulder are stiffness, swelling, and pain. In addition to this, reduction in the shoulder movement is predicted to increase the stiffness in shoulders.  An elongated period of inactivity as a result of injury, surgery, and illness also increases susceptibility to inflammation & adhesion that are bands of stiff tissues.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Frozen Shoulder Treatment Market: Growth Drivers

Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan.

Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years. Massive investments in research activities pertaining to frozen shoulder therapy are projected to create lucrative growth avenues for the market over the forecast timeline.

Frozen Shoulder Treatment Market: Segmentation

The global frozen shoulder treatment market can be classified based on treatment type, route of administration, end-user, and region. In terms of treatment type, the frozen shoulder treatment industry is fragmented into medication, surgery, physical treatment, and joint distension. On the basis of route of administration, the market is segregated into Oral and Parental. End-User wise, the market is divided into Hospitals, Homecare, and Specialty Clinics. Region-wise, the market can be divided into the Middle East and Africa, North America, Latin America Asia Pacific, and Europe.

Frozen Shoulder Treatment Market: Regional Analysis

North America is projected to contribute majorly towards overall market earnings during the forecast timespan. The growth of the regional market over the estimated timeline can be credited to rise in the research activities along with launching of technologically advanced items by the giant firms. Apart from this, advanced treatment procedures for providing quick relief for the subjects suffering from frozen shoulder will prompt the regional market growth over the forecast timespan. Apparently, presence of giant firms in the countries like the U.S. and Canada will promote the regional growth trends.

Competitive Landscape

Key participants profiled in the study include GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp.

 Global Frozen Shoulder Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan. Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years.

The key players profiled in the report include GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp.

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed